106 related articles for article (PubMed ID: 2555061)
1. Growth and differentiation of a human T-cell leukemia cell line, CCRF-CEM, grafted in mice.
Houghton PJ; Mirro J; Goorha RM; Raimondi SC; Fridland A; Houghton JA
Cancer Res; 1989 Dec; 49(24 Pt 1):7124-31. PubMed ID: 2555061
[TBL] [Abstract][Full Text] [Related]
2. Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects.
White S; Taetle R; Seligman PA; Rutherford M; Trowbridge IS
Cancer Res; 1990 Oct; 50(19):6295-301. PubMed ID: 2400993
[TBL] [Abstract][Full Text] [Related]
3. Stable T3- and T3+ subclones derived from the mosaic human T cell leukemia cell line, CEM.
Uppenkamp M; Pittaluga S; Coupland R; Colamonici O; Cossman J
J Immunol; 1988 Apr; 140(8):2802-7. PubMed ID: 2895794
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetic and molecular characterization of tumors in nude mice derived from a multidrug-resistant human leukemia cell line.
Hill AB; Beck WT; Trent JM
Cancer Res; 1988 Jan; 48(2):393-8. PubMed ID: 2891436
[TBL] [Abstract][Full Text] [Related]
6. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome.
Taub JW; Huang X; Ge Y; Dutcher JA; Stout ML; Mohammad RM; Ravindranath Y; Matherly LH
Cancer Res; 2000 Nov; 60(22):6421-6. PubMed ID: 11103808
[TBL] [Abstract][Full Text] [Related]
7. High level expression of the homeobox gene HB24 in a human T-cell line confers the ability to form tumors in nude mice.
Deguchi Y; Kehrl JH
Cancer Res; 1993 Jan; 53(2):373-7. PubMed ID: 8093351
[TBL] [Abstract][Full Text] [Related]
8. Changes in gene expression induced by a phorbol diester: expression of IL 2 receptor, T3, and T cell antigen receptor.
Shackelford DA; Smith AV; Trowbridge IS
J Immunol; 1987 Jan; 138(2):613-9. PubMed ID: 3098850
[TBL] [Abstract][Full Text] [Related]
9. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
10. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of transferrin receptor expression by cultured lymphoblastoid T cells treated with phorbol diesters.
Alcantara O; Denham CA; Phillips JL; Boldt DH
J Immunol; 1989 Mar; 142(5):1719-26. PubMed ID: 2783948
[TBL] [Abstract][Full Text] [Related]
12. Efficient transplantation of human non-T-leukemia cells into nude mice and induction of complete regression of the transplanted distinct tumors by ricin A-chain conjugates of monoclonal antibodies SN5 and SN6.
Hara H; Luo Y; Haruta Y; Seon BK
Cancer Res; 1988 Aug; 48(16):4673-80. PubMed ID: 2969282
[TBL] [Abstract][Full Text] [Related]
13. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
14. Alpha 4 beta 7 integrin expression is associated with the leukemic evolution of human and murine T-cell lymphoblastic lymphomas.
Dolcetti R; Giardini R; Doglioni C; Cariati R; Pomponi F; D'Orazi C; Rao S; Lazarovits AI; Butcher EC; Boiocchi M
Am J Pathol; 1997 May; 150(5):1595-605. PubMed ID: 9137086
[TBL] [Abstract][Full Text] [Related]
15. Trans-acting regulatory factors for T cell antigen receptor alpha- and gamma-chain gene expression.
Maeda K; Nakashima M; Komori S; Watanabe T
J Immunol; 1988 Apr; 140(8):2796-801. PubMed ID: 2833544
[TBL] [Abstract][Full Text] [Related]
16. Alteration in glycosphingolipid pattern during phorbol-12-myristate-13-acetate-induced cell differentiation in human T-lymphoid leukemia cells.
Kiguchi K; Henning-Chubb C; Huberman E
Cancer Res; 1986 Jun; 46(6):3027-33. PubMed ID: 3486042
[TBL] [Abstract][Full Text] [Related]
17. Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice.
Christianson SW; Greiner DL; Schweitzer IB; Gott B; Beamer GL; Schweitzer PA; Hesselton RM; Shultz LD
Cell Immunol; 1996 Aug; 171(2):186-99. PubMed ID: 8806787
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of trimetrexate cytotoxicity in vitro and in vivo by carboxypeptidase G2.
Romanini A; Sobrero AF; Chou TC; Sherwood RF; Bertino JR
Cancer Res; 1989 Nov; 49(21):6019-23. PubMed ID: 2529027
[TBL] [Abstract][Full Text] [Related]
19. Human T cell gamma-chain gene rearrangements in acute lymphoid and nonlymphoid leukemia: comparison with the T cell receptor beta-chain gene.
Greenberg JM; Quertermous T; Seidman JG; Kersey JH
J Immunol; 1986 Sep; 137(6):2043-9. PubMed ID: 3489046
[TBL] [Abstract][Full Text] [Related]
20. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
